A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms

NCT04272957 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hutchison Medipharma Limited